Detalhe da pesquisa
1.
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.
Cancer Immunol Immunother
; 72(7): 2267-2282, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881133
2.
Mapping a route to Indigenous engagement in cancer genomic research.
Lancet Oncol
; 20(6): e327-e335, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162106
3.
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
Cancer Immunol Immunother
; 67(2): 285-298, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29094183
4.
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.
J Neurooncol
; 121(2): 319-29, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25366363
5.
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.
BMC Cancer
; 14: 737, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274181
6.
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.
J Immunother Cancer
; 8(1)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32317292
7.
A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells.
Cancer Chemother Pharmacol
; 84(4): 739-748, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324934
8.
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer.
Clin Cancer Res
; 24(10): 2276-2284, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506988
9.
Gene expression profiling of breast tumours from New Zealand patients.
N Z Med J
; 130(1464): 40-56, 2017 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073656
10.
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
Clin Breast Cancer
; 17(2): 139-153, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756582
11.
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
J Clin Oncol
; 34(15): 1723-31, 2016 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26903575
12.
Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.
J Clin Epidemiol
; 68(8): 895-902, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25843232
13.
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial.
Clin Genitourin Cancer
; 13(1): 50-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25163397
14.
Evidence-based update of chemotherapy options for metastatic colorectal cancer.
ANZ J Surg
; 74(9): 781-7, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15379811
15.
Review of high-dose intravenous vitamin C as an anticancer agent.
Asia Pac J Clin Oncol
; 10(1): 22-37, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24571058
16.
Dietary patterns and information needs of colorectal cancer patients post-surgery in Auckland.
N Z Med J
; 125(1356): 38-46, 2012 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22729057
17.
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity.
Cancer Biol Ther
; 9(9): 717-24, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20234184
18.
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
J Clin Oncol
; 25(16): 2198-204, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17470851